Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for ...

Reports

4

Domains carrying it

4

First reported

15 September 2026

Latest report

17 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 15 September 2026Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for ...markets.businessinsider.com
2. 17 September 2026FDA Approves Generic Lutathera for Adults With GEP-NETsmedscape.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Roche's Tecentriq wins 12th FDA indication, for stage III colon cancer3 reports · 3 domains · 11 October 2026
• FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage ...4 reports · 4 domains · 1 September 2026
• Diabetes Dialogue: Weekly Insulin Efsitora Alfa Gets FDA Approval for Type 2 Diabetes5 reports · 5 domains · 26 September 2026
• Medincell Achieves Major Milestone with U.S. FDA Approval of WELTRUZA™ (olanzapine)15 reports · 14 domains · 10 October 2026
• Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier ...2 reports · 2 domains · 1 September 2026
• Lilly, with new data, to seek FDA approval of obesity drug retatrutide3 reports · 3 domains · 4 August 2026

◆ Share

◆ Evidence

4 reports · 4 domains

• FDA Approves Generic Lutathera for Adults With GEP-NETsmedscape.com · 17 September 2026
• BEXLUTRY Becomes First FDA-Approved Radioligand Equivalent for Adults With SSTR ...hmpgloballearningnetwork.com · 15 September 2026
• Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for ...curiumpharma.com · 15 September 2026
• Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for ...markets.businessinsider.com · 15 September 2026